The Indian Council of Medical examination launched a vaccine trial to prevent the occurrence of TB among close contacts of a TB case patient. This clinical trial for the vaccine is an important step in prevention and decreasing the burden of this disease. Since India has the highest number of TB cases in the world, therefore, Indian Council of Medical Research (ICMR) is undertaking this 1st TB vaccine clinical trial after the famous BCG vaccine trial was undertaken decades back.
After a detailed landscape analysis of the available lead vaccine candidates, two potential vaccine candidates VPM 1002 and MIP were shortlisted for taking forward through the phase III vaccine trial in healthy household contacts of sputum smear-positive TB patient. The two vaccines include VPM1002, which is produced by Serum Institute of India, Pune and the other vaccine is MIP (Mycobacterium Indicus pranii) .…
